Madrigal Pharmaceuticals's total assets for Q1 2025 were $996.63M, a decrease of -4.38% from the previous quarter. MDGL total liabilities were $285.99M for the fiscal quarter, a -0.65% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.